Found: 9
Select item for more details and to access through your institution.
The Carer QALY Trap and Altruism in Economic Evaluations.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1553, doi. 10.1007/s40273-023-01324-0
- By:
- Publication type:
- Article
Modelling Spillover Effects on Informal Carers: The Carer QALY Trap.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1557, doi. 10.1007/s40273-023-01316-0
- By:
- Publication type:
- Article
Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1563, doi. 10.1007/s40273-023-01308-0
- By:
- Publication type:
- Article
Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1589, doi. 10.1007/s40273-023-01297-0
- By:
- Publication type:
- Article
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1603, doi. 10.1007/s40273-023-01294-3
- By:
- Publication type:
- Article
Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1617, doi. 10.1007/s40273-023-01303-5
- By:
- Publication type:
- Article
De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1629, doi. 10.1007/s40273-023-01298-z
- By:
- Publication type:
- Article
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1641, doi. 10.1007/s40273-023-01305-3
- By:
- Publication type:
- Article
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 12, p. 1657, doi. 10.1007/s40273-023-01310-6
- By:
- Publication type:
- Article